reports
Kymera Therapeutics to Unveil New Oral Immunology Program and Report F...
Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025 Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it will host a video webcast from 10:00 a.m. to 11:30 a.m. ET on Friday, May 9, 2025. The company will report first quarter 2025 financial results and also disclose its new oral development candidate targeting a high value undrugged target for mult...
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b ...
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel Phase 2b trials in AD and asthma planned to start in 4Q25 and 1Q26, respectively WATERTOWN, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral...
Hooker Furnishings Reports Improved Sales in Fourth Quarter, Additiona...
Hooker Furnishings Reports Improved Sales in Fourth Quarter, Additional Planned Cost Savings MARTINSVILLE, Va., April 17, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (the “Company” or “HFC”), a global leader in the design, production, and marketing of home furnishings for 101 years, today reported its operating results for its fiscal 2025 fourth quarter and full-year ended February 2, 2025. The fiscal 2025 fourth quarter and full year comprised 14 weeks and 53 weeks, respectively, in contrast to 13 weeks and 52 weeks in the corresponding periods of the previo...
EXL named a Leader and a Star Performer in Everest Group’s 2025 Life a...
EXL named a Leader and a Star Performer in Everest Group’s 2025 Life and Annuities Insurance BPS and TPA PEAK Matrix® Assessment NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- EXL (NASDAQ: EXLS), a global data and AI company, announced it has been named a Leader and a Star Performer in Everest Group’s Life and Annuities (L&A) Insurance Business Process Services (BPS) and Third-Party Administrator (TPA) PEAK Matrix® Assessment 2025. This is the second consecutive year that EXL has earned this distinction. Everest Group cites EXL’s digital integration of analytics and AI solutions, robust en...
EXL Schedules First Quarter 2025 Financial Results Conference Call
EXL Schedules First Quarter 2025 Financial Results Conference Call NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the first quarter ended March 31, 2025, on Tuesday, April 29, 2025, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company’s investor relations website offering an overview of the financial results. The company will host a conference call at 10:00 a.m. EDT the following day, Wednesday, April 30, 2025, with C...
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the appointment of Noah Goodman, M.B.A., as Chief Business Officer. Mr. Goodman brings a wealth of diverse experience in the life sciences industry to Kymera and will lead business development strategy and activities for the company. “We continue to stay focused on our mission of building a fully integra...
Hooker Furnishings to Host Fourth Quarter and Full Year Earnings Call ...
Hooker Furnishings to Host Fourth Quarter and Full Year Earnings Call April 17th MARTINSVILLE, Va., April 03, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) will present its fiscal 2025 fourth quarter and full year financial results via teleconference and live internet web cast on Thursday morning, April 17, 2025 at 9:00 AM Eastern Time. A live webcast of the call will be available on the Investor Relations page of the Company’s website at and archived for replay. To access the call by phone, participants should go to this link ) and you will be provided with ...
Hooker Furnishings to Exit Georgia Distribution Center
Hooker Furnishings to Exit Georgia Distribution Center MARTINSVILLE, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (the “Company” or “HFC”), a global leader in the design, production, and marketing of home furnishings for 101 years, announced its decision to exit its Savannah, Georgia distribution center (“DC”) and consolidate operations in its existing facilities. “Our decision to exit our Savannah, Georgia distribution facility was not taken lightly,” said Jeremy R. Hoff, Hooker’s Chief Executive Officer. “We deeply appreciate the hospitality ...
EXL to Host Investor Strategy Update Event on May 6 in New York
EXL to Host Investor Strategy Update Event on May 6 in New York NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today announced it will be holding an investor strategy update event on May 6, at the NASDAQ MarketSite in Times Square New York. The event will be hosted by Rohit Kapoor, chairman and chief executive officer, along with members of the EXL executive leadership team, focusing on the progression of EXL’s data and AI strategy, new operating model and latest solutions. To register for the event, please click ...
Jaynie Studenmund to Retire From EXL Board of Directors
Jaynie Studenmund to Retire From EXL Board of Directors NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today announced that Jaynie Studenmund has notified EXL’s board of directors that she will not stand for re-election at EXL’s 2025 annual meeting of stockholders and will serve out her current term on the board through June 2025. “On behalf of EXL and its board of directors, we are grateful for the valuable contributions Jaynie has made to the company,” said Rohit Kapoor, chairman and chief executive officer. “Jayni...
ExlService Holdings Inc: 1 director
A director at ExlService Holdings Inc sold/sold after exercising options 10,558 shares at 45.920USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
Hooker Furnishings Declares Quarterly Dividend
Hooker Furnishings Declares Quarterly Dividend MARTINSVILLE, Va., March 05, 2025 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on March 5, 2025, its board of directors declared a quarterly cash dividend of $0.23 per share, payable on March 31, 2025, to shareholders of record on March 17, 2025. Hooker Furnishings Corporation, in its 100th year of business, is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home décor for the residential, hospitalit...
EXL named a Leader in four categories in ISG Provider Lens™ Insurance ...
EXL named a Leader in four categories in ISG Provider Lens™ Insurance Digital Services North America Report NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced it has been named a Leader in four categories in the ISG Provider Lens™ Insurance Services 2024 report. Earning top honors in the North American Life & Retirement Insurance BPO Services, Property & Casualty Insurance BPO, Life & Retirement TPA Insurance Services, and Insurance ITO Services – Midmarket, categories, EXL demonstrated its deep expertise in all aspects of the insurance...
Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financ...
Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update KT-621 (STAT6) Phase 1 healthy volunteer trial ongoing, complete SAD/MAD data expected in June 2025 KT-621 Phase 1b trial in atopic dermatitis (AD) patients expected to initiate in 2Q25 with data in 4Q25, followed by two parallel Phase 2b trials in AD and asthma starting in 4Q25 and 1Q26, respectively KT-295 (TYK2) Phase 1 trial is expected to start in 2Q25, with data expected in 4Q25 KT-474/SAR444656 (IRAK4) Phase 2b trials in hidradenitis suppurativa (HS) and AD ongoing, led...
EXL announces speaker roster for AI in Action virtual event
EXL announces speaker roster for AI in Action virtual event The event will showcase 20 industry experts across businesses highlighting lessons learned in scaling data and AI solutions NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- EXL (NASDAQ: EXLS), a global data and AI company, has unveiled the agenda for its third annual AI in action global event series, featuring keynotes with leaders from EXL, Google, and AWS, as well as a lineup of more than 20 industry CIOs and AI experts. Themed “Driving the Shift to Scalable AI,” the three virtual events will provide actionable strategies to help...
Kymera Therapeutics to Participate in Upcoming March Investor Conferen...
Kymera Therapeutics to Participate in Upcoming March Investor Conferences WATERTOWN, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: TD Cowen 45th Annual Healthcare Conference in Boston, MA on March 5 at 9:10 a.m. ET;Leerink Partners Global Biopharma Conference in Miami, FL on March 11 at 8:00 a.m. ET;Jefferies Biotech on the Bay Summit...
EXL Reports 2024 Fourth Quarter and Year-End Results; Issues 2025 Guid...
EXL Reports 2024 Fourth Quarter and Year-End Results; Issues 2025 Guidance 2024 Fourth Quarter Revenue of $481.4 Million, up 16.3% year-over-yearQ4 Diluted EPS (GAAP) of $0.31, up 28.4% from $0.24 in Q4 of 2023Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.44, up 26.1% from $0.35 in Q4 of 2023 2024 Revenue of $1.84 Billion, up 12.7% year-over-year2024 Diluted EPS (GAAP) of $1.21, up 10.0% from $1.10 in 20232024 Adjusted Diluted EPS (Non-GAAP) (1) of $1.65, up 15.4% from $1.43 in 2023 NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI...
EXL launches EXLerate.AI platform to drive accelerated AI business ben...
EXL launches EXLerate.AI platform to drive accelerated AI business benefits at scale for enterprises EXLerate.AI orchestrates data, digital, and domain-specialized AI solutions to transform mission-critical operations NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data and AI company, announced EXLerate.AI, its agentic AI platform designed to help enterprises reimagine workflows with the ability to seamlessly integrate EXL and third-party AI agents into their business operations. The new platform accelerates progress on the path to greater efficiency, enhanced...
Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financ...
Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27 WATERTOWN, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines with biologics-like activity for immunological diseases, will report fourth quarter and full year 2024 financial results on February 27, 2025. The Company will host a new video conference call format at 8:30 a.m. ET that day. To join the video call or view the livestreamed webcast, please register via , or visit “” in t...
EXL’s LDS platform recognized as ‘Luminary’ in Celent New Business and...
EXL’s LDS platform recognized as ‘Luminary’ in Celent New Business and Underwriting Systems: North America Life Insurance Edition report NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced it has been recognized as a Luminary in the Celent New Business and Underwriting Systems: North America Life Insurance Edition report. The recognition marks the third consecutive year that EXL’s Life Digital Suite™ (LDS) solution, has been honored for its innovation and functionality. In 2022, EXL’s LDS also earned the Luminary honor, and in 2023, EXL...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.